FDA panel backs removal of unproven pregnancy drug

Federal health advisers have concluded that a drug intended to prevent premature births hasn't been shown to work, clearing the way for U.S. regulators to follow through on a long-delayed effort to get it off the market.

Related Keywords

United States ,Washington ,Americans ,Mary Munn ,Robert Califf ,Yolanda Lawson ,Margery Gass ,Margaret Gatz ,Covis Pharma ,University Of South Alabama ,Science Department ,Drug Administration ,Baylor University ,Black Americans ,Associated Press Health ,Howard Hughes Medical Institute ,